journal article·2010-10

The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles

Tae-Hee Kim, Christopher W. Mount, Wayne R. Gombotz, Suzie H. Pun

Biomaterials· Volume 31· Issue 28
Publisher page

Abstract

Doxorubicin (DOX) is an effective chemotherapeutic against a wide range of solid tumors. However, its clinical use is limited by severe side effects such as cardiotoxicity as well as inherent and acquired drug resistance of tumors. DOX encapsulation within self-assembled polymeric micelles has the potential to decrease the systemic distribution of free drug and enhance the drug accumulation in the tumor via the enhanced permeability and retention (EPR). In this study, DOX was encapsulated in micelles composed of poly (ethylene oxide)-poly [(R)-3-hydroxybutyrate]-poly (ethylene oxide) (PEO-PHB-PEO) triblock copolymers. Micelle size, DOX loading and DOX release were characterized. To evaluate DOX activity, micelles were tested in both monolayer cell cultures and three-dimensional (3-D) multicellular spheroids (MCS) that mimic solid tumors. Antitumor activity in vivo was further studied with tumor-bearing mice. The micelles improved the efficiency of Dox penetration in 3-D MCS compared with free DOX. Efficient cell killing by Dox-micelles in both monolayer cells and 3-D MCS was also demonstrated. Finally, DOX-loaded micelles mediate efficient tumor delivery from tail vein injections to tumor-bearing mice with much less toxicity compared with free DOX.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Cancer Research and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (61)

Show source-provided references
1. Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin10.1016/j.jconrel.2009.04.019 ↗
2. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin10.1016/j.biomaterials.2009.09.080 ↗
3. Review of tests for monitoring doxorubicin-induced cardiomyopathy10.1159/000227621 ↗
4. Exploiting the enhanced permeability and retention effect for tumor targeting10.1016/j.drudis.2006.07.005 ↗
5. Intracellular uptake and trafficking of Pluronic micelles in drug-sensitive and MDR cells: effect on the intracellular drug localization10.1002/jps.10006 ↗
6. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy10.1093/jnci/djm043 ↗
7. Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies10.2165/00003088-200342050-00002 ↗
8. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer10.1093/annonc/mdh097 ↗
9. Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels10.1016/j.jconrel.2009.04.010 ↗
10. Drug release characteristics of unimolecular polymeric micelles10.1016/S0168-3659(00)00247-9 ↗
11. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating10.1016/0006-291X(91)91869-E ↗
12. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size
13. Long circulating microparticulate drug carriers10.1016/0169-409X(95)00025-3 ↗
14. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery10.1016/S0169-409X(02)00015-7 ↗
15. Block copolymer micelles: preparation, characterization and application in drug delivery10.1016/j.jconrel.2005.09.034 ↗
16. Dynamic and static light scattering studies on self-aggregation behavior of biodegradable amphiphilic poly(ethylene oxide)-poly[(R)-3-hydroxybutyrate]-poly(ethylene oxide) triblock copolymers in aqueous solution10.1021/jp057004g ↗
17. Synthesis and characterization of new biodegradable amphiphilic poly(ethylene oxide)-b-poly[(R)-3-hydroxy butyratel-b-poly(ethylene oxide) triblock copolymers10.1021/ma025725x ↗
18. Doi · 1990
19. Transport of poly-beta-hydroxybutyrate in human plasma10.1016/0005-2760(92)90168-U ↗
20. In vitro and in vivo degradation studies for development of a biodegradable patch based on poly(3-hydroxybutyrate)10.1016/S0142-9612(01)00405-7 ↗
21. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA)10.1002/jbm.820270904 ↗
22. Distribution kinetics of a micelle-forming block copolymer Pluronic P8510.1016/j.jconrel.2004.09.002 ↗
23. Telechelic diols from poly[(R)-3-hydroxybutyric acid] and poly{[(R)-3-hydroxybutyric acid]-co-[(R)-3-hydroxyvaleric acid]}10.1002/macp.1996.021970503 ↗
24. Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles10.1016/j.ejps.2006.06.003 ↗
25. Increased nanoparticle penetration in collagenase-treated multicellular spheroids
26. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system10.1124/jpet.106.101154 ↗
27. Drug penetration in solid tumours10.1038/nrc1893 ↗
28. Cell and environment interactions in tumor microregions: the multicell spheroid model10.1126/science.2451290 ↗
29. Comparative efficacy of novel platinum(IV) compounds with established chemotherapeutic drugs in solid tumour models10.1016/j.bcp.2003.07.016 ↗
30. Accumulation of an anthraquinone and its platinum complexes in cancer cell spheroids: the effect of charge on drug distribution in solid tumour models10.1039/b902415h ↗
31. 3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers10.1021/bc800233a ↗
32. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages10.4049/jimmunol.148.7.2207 ↗
33. Ultrasound mediated delivery of drugs and genes to solid tumors10.1016/j.addr.2008.03.007 ↗
34. Delivery of viral vectors to tumor cells: extracellular transport, systemic distribution, and strategies for improvement10.1007/s10439-005-9007-2 ↗
35. Multidrug resistance in cancer therapy: role of the microenvironment
36. Acid pH in tumors and its potential for therapeutic exploitation
37. Vascular and interstitial barriers to delivery of therapeutic agents in tumors10.1007/BF00046364 ↗
38. Hypoxia–a key regulatory factor in tumour growth10.1038/nrc704 ↗
39. Effect of therapeutic macromolecules in spheroids10.1016/S1040-8428(00)00084-6 ↗
40. Cytotoxic drug penetration studies in multicellular tumour spheroids10.3109/00498258809041702 ↗
41. Comparison of extracellular matrix in human osteosarcomas and melanomas growing as xenografts, multicellular spheroids, and monolayer cultures
42. Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage?10.1007/BF02897199 ↗
43. The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors10.1158/1078-0432.CCR-05-1664 ↗
44. Doxorubicin gradients in human breast cancer
45. Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin10.1093/jnci/djm027 ↗
46. A perfusable 3D cell-matrix tissue culture chamber for in situ evaluation of nanoparticle vehicle penetration and transport10.1002/bit.21698 ↗
47. Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors10.1073/pnas.081626898 ↗
48. Cationic polymers for gene delivery: designs for overcoming barriers to systemic administration
49. Enhanced percolation and gene expression in tumor hypoxia by PEGylated polyplex micelles10.1038/mt.2009.119 ↗
50. Pharmaceutical and biomedical differences between micellar doxorubicin (NK911) and liposomal doxorubicin (Doxil)10.1111/j.1349-7006.2002.tb01217.x ↗
51. Noninvasive monitoring of the fate of 111In-labeled block copolymer micelles by high resolution and high sensitivity microSPECT/CT imaging10.1021/mp8002418 ↗
52. Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging10.1073/pnas.0707046105 ↗
53. Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells
54. Cellular internalization of PCL(20)-b-PEO(44) block copolymer micelles10.1016/S0005-2736(99)00108-X ↗
55. Micellar nanocontainers distribute to defined cytoplasmic organelles10.1126/science.1078192 ↗
56. Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systems10.1593/neo.06436 ↗
57. In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer10.1021/mp900021q ↗
58. New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting10.1016/j.jconrel.2008.01.007 ↗
59. Block copolymer micelles for drug delivery: design, characterization and biological significance10.1016/S0169-409X(00)00124-1 ↗
60. Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel10.1016/j.colsurfb.2006.04.009 ↗
61. Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells10.1158/1535-7163.MCT-05-0540 ↗